MD
Mirus Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AAViator GMP Platform | Enabling Technology for AAV-based Gene Therapy Manufacturing | Commercial |
| Process Optimization (Rev IT, Complex Stabilizer) | Enabling Technology for Bioprocessing | Commercial |
Leadership Team at Mirus Bio
GS
Geoffrey Schwartz
Chief Executive Officer and General Manager
LJ
Laura Juckem
Vice President, Research and Development
FM
Fletcher Malcom
Director, Strategy, Product and Business Development
JL
Jena Lange
Director, Operations
SH
Scott Hinkelman
Senior Director, Finance